Investigators examined the pharmacokinetics and pharmacodynamics of alemtuzumab in adults with sickle cell disease who received a matched related donor hematopoietic stem cell transplant and determined if the clearance of alemtuzumab affected transplant outcomes.
[Pharmacotherapy]
Sorry, but the selected Zotpress account can't be found.
